Re: “A Whirlwind Year in Review: Trimethoprim-Sulfamethoxazole Versus Placebo for Uncomplicated Skin Abscess” [August 2016]
“This well-designed trial seems to show that patients receiving trimethoprim-sulfamethoxazole following I&D had substantial reduction in both initial treatment failure and abscess recurrence.”
Did anyone ask Dr. Choosing Wisely from ACEP about this one? According to Dr. Wisely, “For patients with uncomplicated skin and soft tissue abscesses successfully treated with incision and drainage, clinicians should provide adequate medical follow-up but avoid antibiotics and wound cultures.”
Have we given CMS another blood-culture-before-antibiotics noose to hang us with?
—Sam Herring, MD